Old Web
English
Sign In
Acemap
>
authorDetail
>
Meghan Wulster-Radcliffe
Meghan Wulster-Radcliffe
Eli Lilly and Company
Duloxetine
Urinary incontinence
Adverse effect
Medicine
Major depressive disorder
5
Papers
166
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial
2008
BMC Urology
Alex T.L. Lin
Mou Jong Sun
Hui-Lung Tai
Yao-Chi Chuang
Shih-Tsung Huang
Nick Wang
Yan D. Zhao
Julie Beyrer
Meghan Wulster-Radcliffe
Louise Levine
Curtis Chang
Lars Viktrup
Show All
Source
Cite
Save
Citations (23)
A retrospective pooled analysis of duloxetine safety in 23 983 subjects
2007
Current Medical Research and Opinion
James Gahimer
Joachim Wernicke
Ilker Yalcin
Melissa J. Ossanna
Meghan Wulster-Radcliffe
Lars Viktrup
Show All
Source
Cite
Save
Citations (88)
Duloxetine versus Placebo for the Treatment of Korean Women with Stress Predominant Urinary Incontinence
2006
Korean Journal of Urology
Sang-Yol Mah
Kyu-Sung Lee
Myung Soo Choo
Ju Tae Seo
Jeong Zoo Lee
Won Hee Park
Joon Chul Kim
Seung Yun Lee
Yan D. Zhao
Julie Beyrer
Meghan Wulster-Radcliffe
Louise Levine
Lars Viktrup
Show All
Source
Cite
Save
Citations (7)
Prostaglandin F2alpha upregulates uterine immune defenses in the presence of the immunosuppressive steroid progesterone.
2006
American Journal of Reproductive Immunology
Gregory S. Lewis
Meghan Wulster-Radcliffe
Show All
Source
Cite
Save
Citations (13)
Safety and adverse event profile of duloxetine
2005
Expert Opinion on Drug Safety
Joachim Wernicke
James Gahimer
Ilker Yalcin
Meghan Wulster-Radcliffe
Lars Viktrup
Show All
Source
Cite
Save
Citations (35)
1